Effect of Liraglutide on Subclinical Atherosclerosis in Patients With Type 1 Diabetes Mellitus

NCT05467514 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

35

Enrollment

OTHER_GOV

Sponsor class

Conditions

Diabetes Mellitus, Type 1

Interventions

DRUG: Liraglutide

Sponsor

David Sanchez Garcia

Collaborators

[object Object]